FDA Approved: KIMMTRAK — Supplemental Application (Immunocore Commercial LLC)

View source ↗

Summary

FDA approved a supplemental application for KIMMTRAK (tebentafusp) filed by Immunocore Commercial LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• KIMMTRAK (tebentafusp)

Snippet

SUPPL AP for KIMMTRAK (TEBENTAFUSP)